filmov
tv
Moderna Focused on Cutting Costs, RSV Vaccine
Показать описание
Moderna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker expects to have its vaccine for respiratory syncytial virus, or RSV, approved in the US this month. He speaks on "Bloomberg Surveillance."
--------
More on Bloomberg Television and Markets
Connect with Bloomberg Television on:
Connect with Bloomberg Business on:
More from Bloomberg:
Watch more on YouTube:
--------
More on Bloomberg Television and Markets
Connect with Bloomberg Television on:
Connect with Bloomberg Business on:
More from Bloomberg:
Watch more on YouTube:
0:08:04
Moderna Focused on Cutting Costs, RSV Vaccine
0:00:49
Moderna CEO explains why the company is going to cut $1.1 billion in costs by 2027
0:07:00
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
![[Cost-Cutting] Moderna -](https://i.ytimg.com/vi/HJyGILrf60U/hqdefault.jpg)
0:04:19
[Cost-Cutting] Moderna - 2024 Q3 Earnings Analysis
0:03:57
Moderna's Stock Crash 2025 What's REALLY Going On?
0:00:56
Moderna CEO defends $130 COVID vaccine price in Senate hearing #shorts
0:04:58
Big Pharma Greed: Moderna’s COVID Vaccines to Cost a Lot More Now | Vantage with Palki Sharma
0:01:33
Sen. Bernie Sanders grills Moderna CEO over Covid vaccine prices during hearing
0:00:29
Sen. Sanders asks CEO if Moderna will reduce vaccine price: 'You guys became billionaires'...
0:01:37
Moderna CEO: 'Vaccines are one of the best investments we can make'
0:01:04
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
0:03:54
PRICE GOUGING: Moderna To Raise Vaccine Prices Over 400%
0:02:48
Moderna shifts focus to developing cancer vaccinations
0:01:00
Big Pharma Greed: Moderna’s COVID Vaccines to Cost a Lot More Now | Vantage with Palki Sharma
0:08:27
Moderna Stock is Crashing! Here’s What You Must Know Before It's Too Late | MRNA Stock Update
2:41:05
Moderna CEO appears before Senate Hearing on COVID-19 vaccine pricing
0:07:36
Moderna CEO on Weak Sales Forecast, Future Acquisitions
0:03:03
Moderna is a 'trade' on Bird Flu vaccine pop, says Mizuho's Jared Holz
0:01:02
CEO of Moderna grilled by lawmakers about plants to quadruple the price of COVID vaccine
0:16:37
Vaccine Safety - Have Moderna Been Hiding Data!?
0:01:05
Moderna's $1.1 Billion Cost Cuts & 17% Stock Drop!
0:07:54
Moderna Inc CEO Stephane Bancel Talks Costs | Bloomberg Talks
0:00:39
Moderna CEO wants an mRNA factory on every continent #ytshorts #moderna #ceo #mrnafactory
0:00:09
WILD $256,000 GAIN OFF $60,000 On Moderna Stock
Комментарии